康艾注射液治疗肺癌的研究进展  

Lung neoplasms Kangai injection Therapy Research progress of Kangai injection in the treatment of lung cancer

作　　者：王硕(综述)[1] 林洪生[1] 董倩(审校)[1] 

机构地区：[1]中国中医科学院广安门医院肿瘤科,北京100053

出　　处：《肿瘤研究与临床》2014年第2期136-139,共4页Cancer Research and Clinic

摘　　要：近年来，康艾注射液作为扶正抗癌类的抗肿瘤中药注射剂，在肿瘤治疗领域的研究十分活跃。对于肺癌患者，康艾注射液单独应用能有效提高生活质量，联合放化疗可提高治疗有效率、增强细胞免疫功能、减轻不良反应，有明显的增效减毒作用。文章对康艾注射液治疗肺癌的研究进展进行综述。In recent years, the research of Kangai injection, which is one of TCM anti-tumor injections, has been recognized as the most active areas of tumor treatment. To lung cancer patients, solo Kangai injection therapy could improve their quaility of life. It can also increase the efficiency, enhance the immune function, decrease the incidence of toxicities and adverse reactions when it has been combined with chemotherapy or radiotherapy. Overall, Kangai injection is effective in improving therapeutic effect and reducing side-effects of chemotherapy or radiotherapy. This article will discuss about recent research status of Kangai injection in the treatment of lung cancer.

关 键 词：肺肿瘤 康艾注射液 治疗 

分 类 号：R730.5[医药卫生—肿瘤]